Evidence map›Paper›PMID 23487599›Full record

Trial reportHypertension (Dallas, Tex. : 1979)2013

Effect of vitamin D supplementation on blood pressure in blacks.

John P Forman, Jamil B Scott, Kimmie Ng, Bettina F Drake, Elizabeth Gonzalez Suarez, Douglas L Hayden, Gary G Bennett, Paulette D Chandler, Bruce W Hollis, Karen M Emmons and 3 more

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 8 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 8 syntheses or guidelines pooled it, 219 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

John P FormanRenal Division and Kidney Clinical Research Institute, Brigham and Women's Hospital, 41 Ave Louis Pasteur, Suite 120, Boston, MA 02115, USA. jforman@partners.org
Jamil B Scott
Kimmie Ng
Bettina F Drake
Elizabeth Gonzalez Suarez
Douglas L Hayden
Gary G Bennett
Paulette D Chandler
Bruce W Hollis
Karen M Emmons
Edward L Giovannucci
Charles S Fuchs
Andrew T Chan
Washington University in St. Louis · USDana-Farber Cancer Institute · USMassachusetts General Hospital · USDuke University · USHarvard University · US

Funding

Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI SHIVDASANI, RAMESH A · 2007 to 2023
$33.2M
VITamin D and omegA-3 triaL (VITAL)U01CA138962 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., MANSON, JOANN ELISABETH · 2009 to 2014
$23.6M
MODifiable Effectors of Renin System Activation: Treatment EvaluationR01HL105440 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FORMAN, JOHN P · 2011 to 2015
$3.5M
Role of Vitamin D, Inflammation, and Energy Balance in Colorectal Cancer SurvivalK07CA148894 · NCI · DANA-FARBER CANCER INST · PI NG, KIMMIE · 2011 to 2015
$889k
Dissemination Research to Reduce Cancer DisparitiesK05CA124415 · NCI · DANA-FARBER CANCER INST · PI EMMONS, KAREN M. · 2007 to 2011
$810k
Community-based Obesity Prevention among BlacksK22CA126992 · NCI · DUKE UNIVERSITY · PI BENNETT, GARY G · 2007 to 2009
$529k
NCI NIH HHS 5K05CA124415NCI NIH HHS K05 CA124415NCI NIH HHS K07 CA148894NCI NIH HHS K07CA148894NCI NIH HHS K22 CA126992NCI NIH HHS K22CA126992NCI NIH HHS P50 CA127003NCI NIH HHS P50CA127003NCI NIH HHS U01 CA138962NHLBI NIH HHS 5R01HL105440NHLBI NIH HHS R01 HL105440
6 · The paper itself

Abstract

Blacks have significantly higher rates of hypertension than whites, and lower circulating levels of 25-hydroxyvitamin D. There are few data about the effect of vitamin D3 (cholecalciferol) supplementation on blood pressure in blacks. During 2 winters from 2008 to 2010, 283 blacks (median age, 51 years) were randomized into a 4-arm, double-blind trial for 3 months of placebo, 1000, 2000, or 4000 international units of cholecalciferol per day. At baseline, 3 months, and 6 months, systolic and diastolic pressure and 25-hydroxyvitamin D were measured. The 3-month follow-up was completed in 250 (88%) participants. The difference in systolic pressure between baseline and 3 months was +1.7 mm Hg for those receiving placebo, -0.66 mm Hg for 1000 U/d, -3.4 mm Hg for 2000 U/d, and -4.0 mm Hg for 4000 U/d of cholecalciferol (-1.4 mm Hg for each additional 1000 U/d of cholecalciferol; P=0.04). For each 1-ng/mL increase in plasma 25-hydroxyvitamin D, there was a significant 0.2-mm Hg reduction in systolic pressure (P=0.02). There was no effect of cholecalciferol supplementation on diastolic pressure (P=0.37). Within an unselected population of blacks, 3 months of oral vitamin D3 supplementation significantly, yet modestly, lowered systolic pressure. Future trials of vitamin D supplementation on blood pressure are needed to confirm these promising results, particularly among blacks, a population for whom vitamin D deficiency may play a more specific mechanistic role in the pathogenesis of hypertension.

Indexed as

Black or African AmericanDietary SupplementsAdministration, OralBlood PressureCholecalciferolDose-Response Relationship, DrugDouble-Blind MethodFollow-Up StudiesHumansHypertensionMassachusettsPrevalenceProspective StudiesTreatment OutcomeVitaminsCholecalciferolVitamins

Identifiers

PMID23487599
PMCPMC3775458
OpenAlexW2524622312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.